Option Care Health, Inc. (NASDAQ:OPCH – Get Rating) gapped up prior to trading on Friday . The stock had previously closed at $30.38, but opened at $31.05. Option Care Health shares last traded at $30.16, with a volume of 561 shares changing hands.
Analyst Ratings Changes
Separately, Barrington Research lifted their price objective on Option Care Health from $37.00 to $38.00 and gave the company an "outperform" rating in a report on Friday, October 28th.
Get
Option Care Health alerts:
Option Care Health Stock Performance
The company has a 50 day moving average price of $30.25 and a 200-day moving average price of $31.11. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.79. The company has a market cap of $5.47 billion, a P/E ratio of 30.70, a price-to-earnings-growth ratio of 2.83 and a beta of 1.19.
Option Care Health (NASDAQ:OPCH – Get Rating) last issued its quarterly earnings results on Thursday, October 27th. The company reported $0.21 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.21. Option Care Health had a return on equity of 11.80% and a net
margin of 4.64%. The company had revenue of $1.02 billion for the quarter, compared to analyst estimates of $994.38 million. On average, equities analysts expect that Option Care Health, Inc. will post 0.79 earnings per share for the current fiscal year.
Insider Activity
In related news, Director R Carter Pate sold 1,928 shares of the business's stock in a transaction on Monday, October 3rd. The stock was sold at an average price of $31.97, for a total transaction of $61,638.16. Following the sale, the director now owns 95,530 shares in the company, valued at approximately $3,054,094.10. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.22% of the company's stock.
Institutional Investors Weigh In On Option Care Health
A number of hedge funds and other institutional investors have recently bought and sold shares of the company. FMR LLC grew its position in Option Care Health by 4.9% during the 2nd quarter. FMR LLC now owns 19,738,359 shares of the company's stock worth $548,530,000 after acquiring an additional 918,277 shares during the last quarter. BlackRock Inc. grew its position in Option Care Health by 20.7% during the 3rd quarter. BlackRock Inc. now owns 19,187,400 shares of the company's stock worth $603,829,000 after acquiring an additional 3,290,272 shares during the last quarter. Vanguard Group Inc. grew its position in shares of Option Care Health by 8.1% in the 3rd quarter. Vanguard Group Inc. now owns 15,269,619 shares of the company's stock valued at $480,534,000 after buying an additional 1,147,767 shares during the last quarter. Marshall Wace LLP grew its position in shares of Option Care Health by 27.1% in the 3rd quarter. Marshall Wace LLP now owns 5,000,053 shares of the company's stock valued at $157,355,000 after buying an additional 1,066,480 shares during the last quarter. Finally, State Street Corp grew its position in shares of Option Care Health by 8.2% in the 3rd quarter. State Street Corp now owns 4,841,602 shares of the company's stock valued at $152,365,000 after buying an additional 365,213 shares during the last quarter. Institutional investors own 97.63% of the company's stock.
About Option Care Health
(Get Rating)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Read More
- Get a free copy of the StockNews.com research report on Option Care Health (OPCH)
- MarketBeat: Week in Review 12/26 – 12/30
- The Dogs Of Tech: It's Time For A Bite Of These Stocks
- Does This Acquisition Make Microsoft a Bear Market Buy?
- Should You Warm up to Generac Stock for the Winter?
- Is Kintara Therapeutics A Hidden Gem?
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.
